PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Search
Dictionary
Mobile
Login
Login/Nickname:
Password:
Remember login
Login
Send password reminder...
W L Gross Selected Research
Wegener Granulomatosis (Wegener's Granulomatosis)
06/2008
Functionally relevant variations of the interleukin-10 gene associated with antineutrophil cytoplasmic antibody-negative Churg-Strauss syndrome, but not with Wegener's granulomatosis.
09/2007
[B lymphocyte differentiation in granulomatous tissues of the lung and the nasal mucosa in Wegener's granulomatosis: origin of anti-neutrophil cytoplasmic antibody formation?]
07/2007
Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis.
07/2006
Lack of efficacy of rituximab in Wegener's granulomatosis with refractory granulomatous manifestations.
02/2005
Association study of Wegener granulomatosis and the functionally relevant A645G polymorphism in the bactericidal/permeability increasing protein (BPI) gene.
10/2004
High-dose intravenous azathioprine pulse treatment in refractory Wegener's granulomatosis.
10/2004
Urinary bladder cancer in Wegener's granulomatosis: is it more than cyclophosphamide?
03/2004
Maintenance of remission with leflunomide in Wegener's granulomatosis.
11/2003
ANCA against the bactericidal/permeability increasing protein (BPI-ANCA) can compromise the antibiotic function of BPI in a Wegener's granulomatosis patient.
11/2002
A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis.
11/2002
Effectiveness of TNF-alpha blockade with infliximab in refractory Wegener's granulomatosis.
09/2002
[Induction of remission with infliximab in therapy-refractory Wegener's granulomatosis - Follow-up of six patients]
04/2002
Elevated monocytic IL-12 and TNF-alpha production in Wegener's granulomatosis is normalized by cyclophosphamide and corticosteroid therapy.
11/2001
Gene polymorphisms of immunoregulatory cytokines and angiotensin-converting enzyme in Wegener's granulomatosis.
09/2001
Severe CNS manifestations as the clinical hallmark in generalized Wegener's granulomatosis consistently negative for antineutrophil cytoplasmic antibodies (ANCA). A report of 3 cases and a review of the literature.
08/2001
Amphipathic variable region heavy chain peptides derived from monoclonal human Wegener's anti-PR3 antibodies stimulate lymphocytes from patients with Wegener's granulomatosis and microscopic polyangiitis.
08/2001
Lack of association between antiphospholipid antibodies and thrombocytopenia in patients with Wegener's granulomatosis.
07/2001
Azathioprine toxicity mimicking a relapse of Wegener's granulomatosis.
03/2001
Polyarthritis following interferon alpha treatment in a patient with localized Wegener's granulomatosis.
05/2000
Anticardiolipin antibodies and antibodies to beta(2)-glycoprotein I in patients with Wegener's granulomatosis.
Articles by Research Topic
Disease
20
Wegener Granulomatosis (Wegener's Granulomatosis)
06/2008 - 05/2000
12
Vasculitis (Vasculitides)
01/2008 - 01/2000
8
Churg-Strauss Syndrome (Allergic Angiitis)
08/2008 - 02/2001
5
Rheumatoid Arthritis
06/2003 - 12/2000
4
Hypertension (High Blood Pressure)
09/2007 - 12/2004
3
Systemic Scleroderma (Systemic Sclerosis)
09/2007 - 12/2004
2
Rheumatic Diseases (Rheumatism)
12/2005 - 02/2001
2
Necrosis
11/2004 - 12/2000
1
Pulmonary Fibrosis (Hamman Rich Syndrome)
09/2007
1
Giant Cell Arteritis (Horton Disease)
09/2006
1
Interstitial Lung Diseases (Interstitial Lung Disease)
09/2006
1
Adult-Onset Still's Disease
08/2006
1
Systemic Lupus Erythematosus (Libman-Sacks Disease)
02/2006
1
Autoimmune Diseases (Autoimmune Disease)
02/2006
1
Peripheral Nervous System Diseases (PNS Diseases)
12/2005
1
Sjogren's Syndrome (Sjogren Syndrome)
07/2005
1
Scleritis (Episcleritis)
07/2005
1
Syndrome
11/2004
1
Panniculitis
11/2004
1
Urinary Bladder Neoplasms (Bladder Cancer)
10/2004
1
Lupus Nephritis
09/2004
1
Infection
11/2003
1
Communicable Diseases (Infectious Diseases)
11/2003
1
Cryoglobulinemia
11/2003
1
Chronic Hepatitis C
11/2003
1
Gram-Negative Bacterial Infections
08/2003
1
Thrombocytopenia (Thrombopenia)
08/2001
1
Arthritis (Polyarthritis)
03/2001
1
Mononeuropathies (Mononeuritis Multiplex)
12/2000
1
Cystic Fibrosis (Mucoviscidosis)
05/2000
1
Subacute Bacterial Endocarditis
01/2000
1
Reactive Arthritis (Reiter Disease)
01/2000
1
Salmonella Infections (Salmonellosis)
01/2000
Drug/Important Bio-Agent (IBA)
20
Antineutrophil Cytoplasmic Antibodies (ANCA)
IBA
06/2008 - 01/2000
5
Methotrexate (Mexate)
FDA Link
Generic
07/2007 - 09/2002
4
rituximab (Mabthera)
FDA Link
08/2006 - 12/2003
4
bactericidal permeability increasing protein
IBA
02/2005 - 05/2000
4
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
06/2003 - 12/2000
4
Antibodies
IBA
08/2001 - 01/2000
3
leflunomide (Arava)
FDA Link
Generic
07/2007 - 03/2004
3
bosentan (Tracleer)
FDA Link
09/2006 - 12/2004
3
Cytokines
IBA
06/2005 - 07/2000
3
Cyclophosphamide (Cytoxan)
FDA Link
Generic
10/2004 - 01/2000
2
Iloprost (Ventavis)
FDA Link
09/2007 - 05/2005
2
Interferon-alpha (Interferon Alfa)
FDA Link
08/2005 - 03/2001
2
Azathioprine (Imuran)
FDA Link
Generic
10/2004 - 07/2001
2
Myeloblastin (Proteinase 3)
IBA
11/2002 - 01/2000
2
infliximab (Remicade)
FDA Link
11/2002 - 09/2002
2
Peroxidase (Myeloperoxidase)
IBA
11/2002 - 02/2001
1
montelukast (Singulair)
FDA Link
08/2008
1
Interleukin-10 (Interleukin 10)
IBA
06/2008
1
HLA-DRB1 antigen (HLA DRB1)
IBA
01/2008
1
Mannose-Binding Lectin (Mannan-Binding Lectin)
IBA
02/2006
1
MHC class II transactivator protein
IBA
02/2006
1
Glucocorticoids
IBA
04/2005
1
Endothelin Receptors (Endothelin Receptor)
IBA
12/2004
1
glucuronyl glucosamine glycan sulfate (Vessel)
IBA
11/2004
1
mycophenolate mofetil (Cellcept)
FDA Link
Generic
09/2004
1
human cationic antimicrobial protein CAP 37
IBA
11/2003
1
Defensins
IBA
11/2003
1
Leukocyte L1 Antigen Complex (Calgranulin)
IBA
11/2003
1
Leukotriene Antagonists (Leukotriene Receptor Antagonists)
IBA
07/2003
1
Cyclosporine (Ciclosporin)
FDA Link
Generic
09/2002
1
Interleukin-12 (IL 12)
IBA
04/2002
1
Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)
IBA
11/2001
1
Peptides
IBA
08/2001
1
Antiphospholipid Antibodies
IBA
08/2001
1
Interleukin-4 (Interleukin 4)
IBA
02/2001
1
Interleukin-13
IBA
02/2001
1
TNFR-Fc fusion protein (etanercept)
FDA Link
12/2000
1
Anticardiolipin Antibodies
IBA
05/2000
1
Complement System Proteins (Complement)
IBA
05/2000
Therapy/Procedure
2
Remission Induction
01/2004 - 09/2002
1
Balloon Angioplasty (Angioplasty, Transluminal)
09/2006
1
Aftercare (After-Treatment)
08/2005
1
Salvage Therapy
09/2002